Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Tianheng Yingrui Pharmaceutical Co., Ltd. is a pharmaceutical manufacturing company based in Meihekou, Jilin Province, China. It serves as a key production facility for the Beijing Tianheng Drug Research Institute, a prominent Chinese pharmaceutical R&D organization. The company specializes in advanced drug delivery systems, particularly osmotic pump controlled-release technology, which it applies to the production of high-quality treatments for chronic metabolic and cardiovascular conditions. Its commercial portfolio includes glipizide and nifedipine controlled-release tablets, as well as botanical-based combination therapies for cardiovascular and cerebrovascular health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Tianheng Yingrui Pharmaceutical.